Plain-English translation of NCT07487064 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new technology called Aliya® pulsed electric field (PEF) treatment for lung cancer. The treatment uses targeted energy pulses to help shrink tumors in the lung before surgery. Researchers want to see if this approach is safe and works well when used just before a planned surgical procedure to remove the affected lung tissue.
Currently, patients with lung cancer typically go directly to surgery to remove the tumor. This new treatment could potentially make tumors easier to remove and improve surgical outcomes by treating the cancer before the operation.
You likely qualify if…
You likely don't qualify if…
If you qualify for this study, you would receive the pulsed electric field treatment at a medical center. Your doctor can deliver this treatment in one of two ways: through a bronchoscope (a thin tube passed through your airways) or through a small needle inserted through your skin, depending on where your tumor is located. After receiving this treatment, you would then proceed with your planned surgery to remove the treated lung tissue, as originally scheduled with your surgical team.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Hong Kong